Image

24.06.2022
Inside the lab: A closer look at retinopathy research
In 2021 we invested £6.6 million into new research, here we take a peek at one of our diabetic retinopath...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in July, including how teplizumab targets type 1 diabetes and understanding the risk of eating disorders for people taking part in type 2 diabetes remission programmes.
Read more